Charles River Laboratories International, Inc. (CRL)
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Last price
- $335.52
- As of
Kresmion compiles this page from CRL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.
See the full CRL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CRL on one page. Preview it with sample data, then open it live with a free account.
Preview the CRL dossierActive events for CRL
- highInsider cluster: sales
2 insiders at CRL sold $9.2M this week
- high13F: large increase
CITADEL ADVISORS LLC added +165% to CRL (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +1328% to CRL (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +22004% to CRL (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 98% of CRL (2026Q2)
FREE, NO ACCOUNT
Every event on CRL, as it fires
You are seeing 5 of 8 events recorded on CRL since 2026-05-26.
The five above landed across 2 days. The other 3 were recorded on 2 other days. 5 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, CRL
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on CRL
- CRL share buybacks Cash paid for repurchases, shares bought and program authorizations, from SEC filings.
- CRL insider trading clusters Three or more insiders filing the same direction within 30 days, from SEC Form 4.
- CRL against its peers Growth, margins and valuation beside the industry median, from annual SEC filings.
CRL against its peers
CRL's operating margin of 0.6% ranks in the 52nd percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | CRL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 4.0B USD | 1.2B USD | 71 | 25 |
| Gross margin | n/a | 59.1% | n/a | 17 |
| Operating margin | 0.6% | -3.8% | 52 | 23 |
| Net margin | -3.6% | -0.3% | 48 | 25 |
| Return on equity | -4.6% | -2.9% | 50 | 24 |
| P / E | n/a | 42.4x | n/a | 11 |
| 1 year | 106.2% | 22.5% | 83 | 25 |
Peers (25): MEDP, TEM, TECH, RGEN, AVTR, BRKR, ILMN, TXG, MTD, IQV, A, SHC, ADPT, ABCL, WAT, FTRE, DHR, MRVI, TMO, MLAB, CTKB, OABI, DNA, PACB, CDXS. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CRL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CRL on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CRL in the last 180 days.
Upstream: SEC EDGAR filings for CRL
Kresmion, "CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) institutional holdings and SEC filings", data as of 2026-11-09, https://kresmion.com/research/CRL. Upstream data: SEC EDGAR filings for CRL.
Link to this data (HTML):
<a href="https://kresmion.com/research/CRL">CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CRL on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CRL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.